422 related articles for article (PubMed ID: 19356789)
1. Coexpression of EphB4 and ephrinB2 in tumor advancement of uterine cervical cancers.
Alam SM; Fujimoto J; Jahan I; Sato E; Tamaya T
Gynecol Oncol; 2009 Jul; 114(1):84-8. PubMed ID: 19356789
[TBL] [Abstract][Full Text] [Related]
2. Overexpression of ephrinB2 and EphB4 in tumor advancement of uterine endometrial cancers.
Alam SM; Fujimoto J; Jahan I; Sato E; Tamaya T
Ann Oncol; 2007 Mar; 18(3):485-90. PubMed ID: 17108150
[TBL] [Abstract][Full Text] [Related]
3. Expression and prognostic significance of EFNB2 and EphB4 genes in patients with oesophageal squamous cell carcinoma.
Tachibana M; Tonomoto Y; Hyakudomi R; Hyakudomi M; Hattori S; Ueda S; Kinugasa S; Yoshimura H
Dig Liver Dis; 2007 Aug; 39(8):725-32. PubMed ID: 17611172
[TBL] [Abstract][Full Text] [Related]
4. Role of protease activated receptor-2 in lymph node metastasis of uterine cervical cancers.
Jahan I; Fujimoto J; Alam SM; Sato E; Tamaya T
BMC Cancer; 2008 Oct; 8():301. PubMed ID: 18937843
[TBL] [Abstract][Full Text] [Related]
5. Coexpression of EphB4 and ephrinB2 in tumour advancement of ovarian cancers.
Alam SM; Fujimoto J; Jahan I; Sato E; Tamaya T
Br J Cancer; 2008 Feb; 98(4):845-51. PubMed ID: 18231102
[TBL] [Abstract][Full Text] [Related]
6. The significance of EphB4 and EphrinB2 expression and survival in head and neck squamous cell carcinoma.
Yavrouian EJ; Sinha UK; Rice DH; Salam MT; Gill PS; Masood R
Arch Otolaryngol Head Neck Surg; 2008 Sep; 134(9):985-91. PubMed ID: 18794445
[TBL] [Abstract][Full Text] [Related]
7. Soluble forms of EphrinB2 and EphB4 reduce retinal neovascularization in a model of proliferative retinopathy.
Zamora DO; Davies MH; Planck SR; Rosenbaum JT; Powers MR
Invest Ophthalmol Vis Sci; 2005 Jun; 46(6):2175-82. PubMed ID: 15914639
[TBL] [Abstract][Full Text] [Related]
8. Correlation of inhibitor of differentiation 1 expression to tumor progression, poor differentiation and aggressive behaviors in cervical carcinoma.
Li J; Jia H; Xie L; Wang X; He H; Lin Y; Hu L
Gynecol Oncol; 2009 Jul; 114(1):89-93. PubMed ID: 19359031
[TBL] [Abstract][Full Text] [Related]
9. Plausible linkage of hypoxia inducible factor-1alpha in uterine cervical cancer.
Fujimoto J; Alam SM; Jahan I; Sato E; Toyoki H; Hong BL; Sakaguchi H; Tamaya T
Cancer Sci; 2006 Sep; 97(9):861-7. PubMed ID: 16805819
[TBL] [Abstract][Full Text] [Related]
10. Loss of basement membrane heparan sulfate expression is associated with pelvic lymph node metastasis in invasive cervical cancer.
Kodama J; Shinyo Y; Hasengaowa ; Kusumoto T; Seki N; Nakamura K; Hongo A; Hiramatsu Y
Oncol Rep; 2005 Jul; 14(1):89-92. PubMed ID: 15944773
[TBL] [Abstract][Full Text] [Related]
11. Expression of MMP9 and CD147 in invasive squamous cell carcinoma of the uterine cervix and their implication.
Yu W; Liu J; Xiong X; Ai Y; Wang H
Pathol Res Pract; 2009; 205(10):709-15. PubMed ID: 19541433
[TBL] [Abstract][Full Text] [Related]
12. The expression of MAGE and GAGE genes in uterine cervical carcinoma of Korea by RT-PCR with common primers.
Chang HK; Park J; Kim W; Kim K; Lee M; Park U; Choi B
Gynecol Oncol; 2005 May; 97(2):342-7. PubMed ID: 15863128
[TBL] [Abstract][Full Text] [Related]
13. [Detecting protein expression of EphrinB2 ligand and its receptor EphB4 in astrocytoma using confocal laser scanning microscopy].
Xiao HL; Bian XW; Li ZP; Long ZY; Wang D
Ai Zheng; 2004 Oct; 23(10):1161-5. PubMed ID: 15473927
[TBL] [Abstract][Full Text] [Related]
14. Human leukocytes express ephrinB2 which activates microvascular endothelial cells.
Zamora DO; Babra B; Pan Y; Planck SR; Rosenbaum JT
Cell Immunol; 2006 Aug; 242(2):99-109. PubMed ID: 17123494
[TBL] [Abstract][Full Text] [Related]
15. The association between elevated EphB4 expression, smoking status, and advanced-stage disease in patients with head and neck squamous cell carcinoma.
Sinha UK; Mazhar K; Chinn SB; Dhillon VK; Liu L; Masood R; Rice DH; Gill PS
Arch Otolaryngol Head Neck Surg; 2006 Oct; 132(10):1053-9. PubMed ID: 17043250
[TBL] [Abstract][Full Text] [Related]
16. Expression of EphB4 in head and neck squamous cell carcinoma.
Sinha UK; Kundra A; Scalia P; Smith DL; Parsa B; Masood R; Gill PS
Ear Nose Throat J; 2003 Nov; 82(11):866, 869-70, 887. PubMed ID: 14661437
[TBL] [Abstract][Full Text] [Related]
17. Soluble form of ephrinB2 inhibits xenograft growth of squamous cell carcinoma of the head and neck.
Kimura M; Kato Y; Sano D; Fujita K; Sakakibara A; Kondo N; Mikami Y; Tsukuda M
Int J Oncol; 2009 Feb; 34(2):321-7. PubMed ID: 19148465
[TBL] [Abstract][Full Text] [Related]
18. Increased expression of SKP2 and phospho-MAPK/ERK1/2 and decreased expression of p27 during tumor progression of cervical neoplasms.
Chen TP; Chen CM; Chang HW; Wang JS; Chang WC; Hsu SI; Cho CL
Gynecol Oncol; 2007 Mar; 104(3):516-23. PubMed ID: 17079005
[TBL] [Abstract][Full Text] [Related]
19. Prognostic value of EphA2 and EphrinA-1 in squamous cell cervical carcinoma.
Wu D; Suo Z; Kristensen GB; Li S; Troen G; Holm R; Nesland JM
Gynecol Oncol; 2004 Aug; 94(2):312-9. PubMed ID: 15297167
[TBL] [Abstract][Full Text] [Related]
20. Clinical significance of matrix metalloproteinase-2 in cancer of uterine cervix: a semiquantitative study of immunoreactivities using tissue array.
Wang PH; Ko JL; Tsai HT; Yang SF; Han CP; Lin LY; Chen GD
Gynecol Oncol; 2008 Mar; 108(3):533-42. PubMed ID: 18177928
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]